Paper1849409
Eosinophil activation in systemic sclerosis.
Gustafsson R and 3 others. Arthritis Rheum, 1991. Cited by 57 papers, by iCite.
Cite this record
ConductScience Library. Eosinophil activation in systemic sclerosis. Papers, record 1849409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1849409
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Proteins | Major topic |
| Eosinophils | Major topic |
| Ribonucleases | Major topic |
| Scleroderma, Systemic | Major topic |
| Adult | |
| Aged | |
| Biopsy | |
| Bronchoalveolar Lavage Fluid | |
| Environmental Exposure | |
| Eosinophil Granule Proteins | |
| Extracellular Space | |
| Female | |
| Humans | |
| Inflammation | |
| Male | |
| Middle Aged | |
| Silicon Dioxide | |
| Skin |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42979116 | Eosinophils in autoimmune diseases: context-dependent pathogenesis, functional heterogeneity, and therapeutic translation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42979116 | PubMed |
| 37392249 | Type 2 cytokines and scleroderma interstitial lung disease. | Clin Exp Med | 2023 | https://conductscience.org/library/papers/37392249 | PubMed |
| 27610320 | Associations between peripheral blood eosinophil counts in patients with systemic sclerosis and disease severity. | Springerplus | 2016 | https://conductscience.org/library/papers/27610320 | PubMed |
| 15677539 | Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis. | J Clin Pathol | 2005 | https://conductscience.org/library/papers/15677539 | PubMed |
| 15008974 | The effect of eosinophils on collagen gel contraction and implications for tissue remodelling. | Clin Exp Immunol | 2004 | https://conductscience.org/library/papers/15008974 | PubMed |
| 11123102 | The Th1/Th2 paradigm in the pathogenesis of scleroderma, and its modulation by thalidomide. | Curr Rheumatol Rep | 2000 | https://conductscience.org/library/papers/11123102 | PubMed |
| 10473513 | Increased levels of alternatively spliced interleukin 4 (IL-4delta2) transcripts in peripheral blood mononuclear cells from patients with systemic sclerosis. | Clin Diagn Lab Immunol | 1999 | https://conductscience.org/library/papers/10473513 | PubMed |
| 9403725 | Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. | Am J Pathol | 1997 | https://conductscience.org/library/papers/9403725 | PubMed |
| 7979595 | Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjögren's syndrome. | Ann Rheum Dis | 1994 | https://conductscience.org/library/papers/7979595 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| RNASE3 | 6037 | PubTator's text mining | https://conductscience.org/library/genes/6037 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1849409
GET https://conductscience.org/api/papers/v1/1849409/authors